Delivery Order SPE2DE21D7020-SPE2D625F7K1W
- Not listed
- Boston Scientific Corp, a major global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $32,850 by the Defense Health Agency's Medical Supply Chain under contract 4569047952. This fixed-price delivery order with economic price adjustment terms carries an ultimate completion date of August 18, 2025, and was issued on August 11, 2025. The contract is not set-aside and represents Boston Scientific's continued role as a prime...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $11,312.43 by the Defense Health Agency's Medical Supply Chain program. The contract, awarded on August 14, 2025, with an ultimate completion date of August 21, 2025, utilizes fixed-price pricing with economic price adjustment. The delivery order is to be performed at Boston Scientific's facility in Marlborough, MA, and no small business set-aside...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $4,505.50 by the Defense Health Agency's Medical Supply Chain on August 5, 2025. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of August 12, 2025 and involves performance at Boston Scientific's facility in Marlborough, MA. The award was made without a set-aside designation, allowing the company...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order with economic price adjustment valued at $4,860 by the Defense Health Agency's Medical Supply Chain division on September 2, 2025. The delivery order, with an ultimate completion date of September 9, 2025, represents a short-duration task order for specialized medical devices or equipment. As a major federal contractor, Boston Scientific supplies...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $2,157.35 by the Defense Health Agency's Medical Supply Chain on August 19, 2025. The contract covers a Selective MC Single Bern 130CM medical device and carries an ultimate completion date of August 26, 2025. This fixed-price delivery order with economic price adjustment represents one of numerous federal contract awards Boston Scientific...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $6,118.95 by the Defense Health Agency's Medical Supply Chain on September 16, 2025. This fixed-price contract with economic price adjustment provisions has an ultimate completion date of September 23, 2025 and carries no set-aside designation, indicating open competition in the federal marketplace. The work will be performed at Boston Scientific's...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $5,120.00 by the Defense Health Agency's Medical Supply Chain division. The contract, issued on June 30, 2025, with an ultimate completion date of July 11, 2025, covers NRG EEPROM high flow 98cm medical equipment under a fixed-price contract with economic price adjustment terms. The place of performance is Boston Scientific's facility in...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $2,475.34 by the Defense Health Agency's Medical Supply Chain on September 12, 2025. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by September 19, 2025, and represents work to be performed at the company's facility in Marlborough, Massachusetts. The contract carries no set-aside designation,...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $75,560 by the Defense Health Agency's Medical Supply Chain on August 20, 2025, with an ultimate completion date of September 10, 2025. This fixed-price contract with economic price adjustment provisions represents a non-competitive award with no small business set-aside. As the place of performance is Boston Scientific's headquarters location in...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $5,050.68 by the Defense Health Agency's Medical Supply Chain program. The contract, issued on August 4, 2025, with an ultimate completion date of August 11, 2025, utilizes fixed-price pricing with economic price adjustment terms and carries no set-aside designation. The place of performance is Boston Scientific's facility in Marlborough,...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F7K1WDelivery Order
Boston Scientific Corp, a global medical device manufacturer headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $2,525.83 by the Defense Health Agency's Medical Supply Chain program. The contract, issued on May 13, 2025, with an ultimate completion date of May 20, 2025, is structured as a fixed-price delivery order with economic price adjustment provisions. The award involves the supply of NG SYN MR US 20MM medical devices, with performance occurring at Boston Scientific's Marlborough, Massachusetts facility. No set-aside designation was applied to this award, indicating open competition in the federal marketplace. This delivery order represents one of numerous awards Boston Scientific has received through the DHA's Medical Supply Chain program, reflecting the company's established role as a critical supplier of specialized medical technologies to federal healthcare agencies. Boston Scientific's federal contract portfolio demonstrates comprehensive capabilities across cardiovascular, interventional, and diagnostic medical equipment categories. The company maintains multiple indefinite delivery vehicles with federal healthcare agencies, including a significant $750,000 blanket purchase agreement with the DHA for radiation treatment devices extending through March 30, 2030, positioning it as a strategic supplier for advanced medical device solutions across the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 5/13/25 |